Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antiretroviral Regimens and Body Fat Changes in HIV
NCT00005106Phase 4Completed
- Sponsor
- GSK
- Start
- Sep 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of abacavir in human immunodeficiency virus infection (HIV) (3 arms), sponsored by GSK. Primary endpoint: Body Fat Composition Changes at 96 weeks. Started Sep 1999; status: completed.
02
Drugs
abacavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00005106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005106.